Research ArticleClinical Investigations
Microfluidic Preparation of a 89Zr-Labeled Trastuzumab Single-Patient Dose
Brian D. Wright, Joseph Whittenberg, Amit Desai, Christina DiFelice, Paul J.A. Kenis, Suzanne E. Lapi and David E. Reichert
Journal of Nuclear Medicine May 2016, 57 (5) 747-752; DOI: https://doi.org/10.2967/jnumed.115.166140
Brian D. Wright
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri; and
Joseph Whittenberg
2Department of Chemical & Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois
Amit Desai
2Department of Chemical & Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois
Christina DiFelice
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri; and
Paul J.A. Kenis
2Department of Chemical & Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois
Suzanne E. Lapi
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri; and
David E. Reichert
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 5
May 1, 2016
Microfluidic Preparation of a 89Zr-Labeled Trastuzumab Single-Patient Dose
Brian D. Wright, Joseph Whittenberg, Amit Desai, Christina DiFelice, Paul J.A. Kenis, Suzanne E. Lapi, David E. Reichert
Journal of Nuclear Medicine May 2016, 57 (5) 747-752; DOI: 10.2967/jnumed.115.166140